Is CAI research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CAI. It does not provide personalized investment advice.

CAI (Caris Life Sciences, Inc. Common Stock) Stock Analysis - Financials

Caris Life Sciences, Inc. Common Stock (CAI) is a publicly traded Healthcare sector company. As of September 4, 2026, CAI trades at $25.26 with a market cap of $7.01B and a P/E ratio of 14.58. CAI moved -0.26% today. Year to date, CAI is -6.15%; over the trailing twelve months it is -30.34%. Its 52-week range spans $14.19 to $42.50. Analyst consensus is buy with an average price target of $26.29. Rallies surfaces CAI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are CAI's key financials?

CAI financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CAI recently traded at $25.26. Market cap is $7.01B. P/E ratio is 14.58. Revenue is $989.61M.

CAI Key Metrics

Key financial metrics for CAI
Metric	Value
Price	$25.26
Market Cap	$7.01B
P/E Ratio	14.58
EPS	$1.70
Dividend Yield	0.30%
52-Week High	$42.50
52-Week Low	$14.19
Volume	18.02K
Avg Volume	0
Revenue (TTM)	$989.61M
Net Income	$105.14M
Gross Margin	0.00%

CAI Analyst Consensus

9 analysts cover CAI: 0 strong buy, 6 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $26.29.

Common questions about CAI

What are CAI's key financials?: CAI financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CAI recently traded at $25.26. Market cap is $7.01B. P/E ratio is 14.58. Revenue is $989.61M.
Is CAI research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CAI. It does not provide personalized investment advice.